NYU Langone Takotsubo Study Release Form
DC 08/09/2019 FOR NYU TAKOTSUBO STUDY MEDICAL RECORD RELEASE ONLY Authorization for the Use & Disclosure ...
NYU Langone to Enroll Volunteers in COVID-19 Vaccine Trial
NYU Langone’s Vaccine Center is helping test the effectiveness of a COVID-19 vaccine developed by the pharmaceutical company AstraZeneca.
NYU Langone to Lead Federal Research on “Long COVID” Effects
Millions of people have debilitating long-term COVID-19 symptoms; NYU Langone researchers will direct an NIH initiative to advance treatments.
NYU Langone to Lead Research on COPD Breath Test
$225,000 NIH grant to develop a breath test for COPD will identify volatile organic compound biomarkers in human breath.
NYU Langone to Lead Transformation of NYC Medical Practices
NYU Langone has been awarded $7 million from Health and Human Services to fund practice transformation for clinicians in New York City.
NYU Langone to Study COVID-19’s Long-Term Effects
NYU Langone Health has won a $52 million grant to lead clinical centers nationally in studying COVID-19 long haul symptoms.
NYU Langone to Study Impact of Overdose Prevention Centers
NYU Langone and Brown University researchers will measure the effectiveness of overdose prevention centers (OPCs) in New York and Providence, RI.
NYU Langone Tops Stroke, Critical & Pulmonary Care in State
NYU Langone is the state’s top-ranked hospital in critical care, pulmonary care, and stroke care in Healthgrades’ 2022 rankings.
NYU Langone Tops Transplant Programs in New York
NYU Langone Transplant Institute teams performed 600 organ transplants in 2022, exceeding any single transplant center in the Northeast.
NYU Langone Transplant Institute Marks Milestone Procedure
NYU Langone Transplant Institute celebrates its 100th lung transplant procedure, providing two new lungs to a woman recovering from COVID-19.